SPY326.97-3.68 -1.11%
DIA271.44-5.08 -1.84%
IXIC10,778.80-14.48 -0.13%

OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program

ELMWOOD PARK, N.J., Sept. 2, 2020 /PRNewswire/ --BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for

· 09/02/2020 08:12

ELMWOOD PARK, N.J., Sept. 2, 2020 /PRNewswire/ --BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for COVID-19, across the five boroughs, in preparation for a safer back-to-school environment.

Through a strategic collaboration with BioReference, New York City, the Department of Health and New York City Health and Hospital Corporation (NYC Health + Hospitals) will collect specimens from principals, teachers and staff members across eight locations. BioReference will then perform COVID-19 PCR tests for the principals, teachers and other school staff at its Elmwood Park, New Jersey laboratory facility. The hours of operation for collection of specimens will be 8:00 a.m. to 8:00 p.m. ET, Monday through Sunday, beginning today and concluding Monday, September 7. Registration and appointment selection is required. To register for collection of a specimen for a COVID-19 test, visit: https://appointments.bioreference.com/nycschools.